|
Bifunctional T cell receptor based immunotherapeutics
|
2R44CA097550-05A1
|
$1,000,000
|
$250,000
|
WONG, HING
|
ALTOR BIOSCIENCE CORPORATION
|
|
American College of Radiology Imaging Network
|
5U01CA080098-11
|
$8,896,390
|
$444,820
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Primary Xenografts of Human Tissue as Surrogates of Cancer In Situ
|
1R43CA137737-01
|
$139,945
|
$69,973
|
Zwick, Michael
|
ANDROBIOSYS, INC.
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-20
|
$521,201
|
$5,212
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
DF/HCC Kidney Cancer SPORE
|
2P50CA101942-06A1
|
$2,300,000
|
$2,300,000
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-11
|
$130,866
|
$10,469
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Targeting the PI3-Kinase/Akt Pathway for the Therapy of Renal Cell Carcinoma
|
1K08CA142890-01
|
$169,400
|
$169,400
|
Cho, Daniel
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Mechanisms of Hemidesmosome Disassembly: Role of a6b4 integrin phosphorylation
|
5R01CA120202-03
|
$290,700
|
$29,070
|
RABINOVITZ, ISAAC
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
MAGIC ROUNDABOUT (MRB), A TUMOR ENDOTHELIAL MARKER
|
5K01CA104700-05
|
$153,629
|
$153,629
|
SETH, PANKAJ
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Novel vitamin D analog for kidney cancer
|
5R21CA127629-02
|
$219,375
|
$219,375
|
RAY, RAHUL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Analgesic Use and Kidney Cancer
|
5R03CA137764-02
|
$87,070
|
$87,070
|
CHO, EUNYOUNG
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Carle Cancer Center Community Clinical Oncology Program
|
5U10CA035195-26
|
$841,092
|
$16,822
|
ROWLAND, KENDRITH
|
CARLE CLINIC ASSOCIATION, P C
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-35
|
$417,370
|
$33,390
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-20S2
|
$70,196
|
$702
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-20S3
|
$99,890
|
$999
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-20
|
$4,865,452
|
$48,655
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Cedar Rapids Oncology Project
|
5U10CA052352-20
|
$446,062
|
$8,921
|
WIESENFELD, MARTIN
|
CEDAR RAPIDS ONCOLOGY PROJECT
|
|
Pathophysiology of Post-Transplantation Cancer
|
1R01CA131145-01A2
|
$352,751
|
$352,751
|
Pal, Soumitro
|
CHILDREN'S HOSPITAL BOSTON
|
|
Genetics of pediatric rhabdoid tumors
|
5R01CA046274-18
|
$266,860
|
$90,732
|
BIEGEL, JACLYN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Delaware/Christiana Care CCOP
|
5U10CA045418-23
|
$1,282,700
|
$12,827
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
City of Hope Southwest Oncology Group Clinical Trials
|
5U10CA046368-22
|
$332,211
|
$3,322
|
MORTIMER, JOANNE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Southwest Oncology Group
|
5U10CA004919-50
|
$195,727
|
$1,957
|
BUDD, G
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Tumor Induced Dysregulation of T Cell Immunity
|
5R01CA116255-04
|
$261,665
|
$261,665
|
FINKE, JAMES
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
CCOP: Colorado Cancer Research Program
|
5U10CA067753-14
|
$1,053,364
|
$21,067
|
Pajon, Eduardo
|
COLORADO CANCER RESEARCH PROGRAM, INC.
|
|
The role of angiopoietins in Wilms tumor
|
5K08CA107077-05
|
$134,946
|
$134,946
|
HUANG, JIANZHONG
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Columbus Community Clinical Oncology Program
|
5U10CA035261-26
|
$930,000
|
$18,600
|
KUEBLER, J
|
COLUMBUS COMMUNITY CLINICAL ONCOLOGY PRG
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S1
|
$124,531
|
$1,245
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S2
|
$100,000
|
$1,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S5
|
$143,383
|
$1,434
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-45
|
$11,688,901
|
$116,889
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
ECOG Statistical Office
|
5U10CA023318-33
|
$2,407,336
|
$192,587
|
GRAY, ROBERT
|
DANA-FARBER CANCER INSTITUTE
|
|
Functional Analysis of the Von Hippel-Lindau Protein
|
5R01CA068490-14
|
$297,903
|
$297,903
|
KAELIN, WILLIAM
|
DANA-FARBER CANCER INSTITUTE
|
|
Exploiting mouse models of pediatric cancers and epigenetics for therapy
|
2U01CA105423-06
|
$835,000
|
$275,550
|
ORKIN, STUART
|
DANA-FARBER CANCER INSTITUTE
|
|
Cellular Consequences of Snf5 Tumor Suppressor Loss
|
5F32CA123776-03
|
$57,194
|
$57,194
|
Sansam, Courtney
|
DANA-FARBER CANCER INSTITUTE
|
|
Immunotherapy for Renal Cell Carcinoma
|
5R01CA095648-05
|
$405,348
|
$405,348
|
ERNSTOFF, MARC
|
DARTMOUTH COLLEGE
|
|
Central Illinois Community Clinical Oncology Program
|
5U10CA045807-24
|
$1,370,000
|
$27,400
|
WADE, JAMES
|
DECATUR MEMORIAL HOSPITAL
|
|
Eastern Cooperative Oncology Group Chair's Office
|
5U10CA086802-11
|
$655,420
|
$52,434
|
COMIS, ROBERT
|
DREXEL UNIVERSITY
|
|
Molecular Mechanisms of E2F Specificity
|
5R01CA104663-07
|
$338,986
|
$338,986
|
NEVINS, JOSEPH
|
DUKE UNIVERSITY
|
|
Duluth Community Clinical Oncology Program
|
5U10CA035269-26
|
$747,046
|
$14,941
|
Nikcevich, Daniel
|
DULUTH CLINIC, LTD.
|
|
Emory-GA Tech Nanotechnology Center for Personalized an*
|
5U54CA119338-05
|
$3,691,806
|
$369,181
|
NIE, SHUMING
|
EMORY UNIVERSITY
|
|
EORTC DATA CENTER
|
5U10CA011488-39
|
$809,323
|
$16,186
|
Sylvester, Richard
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
Community Clinical Oncology Program: FL Pediatric CCOP
|
5U10CA035157-26
|
$382,772
|
$7,655
|
TALBERT, JAMES
|
FLORIDA ASSN OF PEDIATRIC TUMOR PROG
|
|
Methylation & Proteomics-Based Detection of Renal Cancer
|
3U01CA111242-05S1
|
$282,254
|
$282,254
|
CAIRNS, PAUL
|
FOX CHASE CANCER CENTER
|
|
Eastern Cooperative Oncology Group
|
5U10CA027525-31
|
$453,259
|
$36,261
|
GOLDSTEIN, LORI
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-47S1
|
$118,679
|
$2,374
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-47S2
|
$127,851
|
$2,557
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-47S3
|
$100,000
|
$2,000
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
5P30CA006927-47
|
$8,241,288
|
$164,826
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Late Effects of Treatment in Wilms Tumor Survivors and Offspring
|
5R01CA054498-18
|
$1,023,737
|
$1,023,737
|
BRESLOW, NORMAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Southwest Oncology Group Statistical Center
|
5U10CA038926-24
|
$4,746,162
|
$47,462
|
CROWLEY, JOHN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
Total relevant funding to Kidney Cancer for this search: $45,197,735
|